Actual Medicinal Product (AMP) Sitagliptin 50mg / Metformin 1g tablets (Medical Valley Invest AB)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Original packaging may contain desiccant. No stability data in MCAs available.
- Provenance
-
This recommendation is based on the products Janumet 50mg/1000mg film-coated tablets (Merck, Sharpe and Dohme Limited) and Sitagliptin-Metformin 50mg/1000mg film-coated tablets. (Genus Pharmaceuticals).
- Generic
- Sitagliptin + Metformin
- Formulation
- Sitagliptin 50mg / Metformin 1g tablets
-
Sitagliptin + Metformin
-
Sitagliptin 50mg / Metformin 1g tablets
-
Sitagliptin 50mg / Metformin 1g tablets (Medical Valley Invest AB)
-
-